EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway

Ze-Yi Tang, Xiao-Min Wang, Chun-Wei Xu, Qing-Qing Sun, Yu-Xin Hua, Qi-Yin Zhou, Han-Yin Hu, Sheng-Bing Liu, Yan-Jun Guo, Lei Ao, Xuan Che, Xian-Chao Zhang und 7 weitere

Cellular and Molecular Life Sciences · 2024-12 · 81 (1)

DOI: 10.1007/s00018-024-05446-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Life Sciences, online erschienen am 05.10.2024. Verfasst von Ze-Yi Tang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, College of Medicine, Jiaxing University, 118 Jiahang Road, Jiaxing, 314001, P. R. China. Hauptthemen laut MEDLINE: Cell Movement, Cell Proliferation, Focal Adhesion Kinase 1, Mice, Nude. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Zhejiang Provincial Foreign Expert Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cullin-RING ubiquitin ligase 4 (CRL4) is closely correlated with the incidence and progression of ovarian cancer. DDB1- and CUL4-associated factor 13 (DCAF13), a substrate-recognition protein in the CRL4 E3 ubiquitin ligase complex, is involved in the occurrence and development of ovarian cancer. However, its precise function and the underlying molecular mechanism in this disease remain unclear. In this study, we confirmed that DCAF13 is highly expressed in human ovarian cancer and its expression is negatively correlated with the overall survival rate of patients with ovarian cancer. We then used CRISPR/Cas9 to knockout DCAF13 and found that its deletion significantly inhibited the proliferation, colony formation, and migration of human ovarian cancer cells. In addition, DCAF13 deficiency inhibited tumor proliferation in nude mice. Mechanistically, CRL4-DCAF13 targeted Fraser extracellular matrix complex subunit 1 (FRAS1) for polyubiquitination and proteasomal degradation. FRAS1 influenced the proliferation and migration of ovarian cancer cell through induction of the focal adhesion kinase (FAK) signaling pathway. These findings collectively show that DCAF13 is an important oncogene that promotes tumorigenesis in ovarian cancer cells by mediating FRAS1/FAK signaling. Our findings provide a foundation for the development of targeted therapeutics for ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MovementCell ProliferationFocal Adhesion Kinase 1Mice, NudeOvarian NeoplasmsRNA-Binding ProteinsExtracellular Matrix ProteinsAnimalsFemaleHumansMiceCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticMice, Inbred BALB CSignal TransductionUbiquitination

Stichwörter der Autor:innen

CRL4 E3 ubiquitin ligaseDCAF13FAKFRAS1Ovarian cancer

Substanzen

Focal Adhesion Kinase 1PTK2 protein, humanDCAF13 protein, humanRNA-Binding ProteinsFRAS1 protein, humanExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Cell Biology, College of Medicine, Jiaxing University, 118 Jiahang Road, Jiaxing, 314001, P. R. China.
  • Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P. R. China.
  • Department of Pharmacy, Xinhua Hospital, School of Medicine, Affiliated to Shanghai Jiao Tong University, Shanghai, 200092, China.
  • Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, No. 1 Banshan East Street, Gongshu District, Hangzhou, 310022, China.
  • Zhejiang Chinese Medicine University and Jiaxing University Master Degree Cultivation Base, Jiaxing University, 118 Jiahang Road, Jiaxing, 314001, P. R. China.
  • Department of Anesthesiology, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children Hospital, Jiaxing University, Jiaxing, 314001, P. R. China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Zhejiang Provincial Foreign Expert Grant
  • Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics
  • Dutch Cancer Foundation
  • Jiaxing talent pioneer innovation team

Zitieren

APA

Tang, Z. Y., Wang, X. M., Xu, C. W., Sun, Q. Q., Hua, Y. X., Zhou, Q. Y., Hu, H. Y., Liu, S. B., Guo, Y. J., Ao, L., Che, X., Zhang, X. C., Heger, M., Zheng, X., Liu, A. J., Wang, Q., Zhan, Z. J., Cheng, S. Q., & Pan, W. W. (2024). DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway. Cellular and Molecular Life Sciences, 81(1). https://doi.org/10.1007/s00018-024-05446-2

Vancouver

Tang ZY, Wang XM, Xu CW, Sun QQ, Hua YX, Zhou QY, et al. DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway. Cellular and Molecular Life Sciences. 2024;81(1). doi:10.1007/s00018-024-05446-2

BibTeX
@article{Tang2024,
  author = {Tang, Ze-Yi and Wang, Xiao-Min and Xu, Chun-Wei and Sun, Qing-Qing and Hua, Yu-Xin and Zhou, Qi-Yin and Hu, Han-Yin and Liu, Sheng-Bing and Guo, Yan-Jun and Ao, Lei and Che, Xuan and Zhang, Xian-Chao and Heger, Michal and Zheng, Xin and Liu, Ai-Jun and Wang, Qian and Zhan, Zha-Jun and Cheng, Shu-Qun and Pan, Wei-Wei},
  title = {DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway},
  journal = {Cellular and Molecular Life Sciences},
  year = {2024},
  volume = {81},
  number = {1},
  doi = {10.1007/s00018-024-05446-2}
}
Kostenlos starten →